J
Jinying Zhang
Researcher at Nanjing Medical University
Publications - 11
Citations - 259
Jinying Zhang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Immunotherapy & Cytokine-induced killer cell. The author has an hindex of 7, co-authored 11 publications receiving 183 citations.
Papers
More filters
Journal ArticleDOI
A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Huo Zhang,Mingxia Zhu,Xia Shan,Xin Zhou,Tongshan Wang,Jinying Zhang,Jinsong Tao,Wenfang Cheng,Gang Chen,Jian Li,Ping Liu,Qiang Wang,Wei Zhu +12 more
TL;DR: A seven-miRNA signature in the peripheral plasma for CRC detection was established and seven miRNAs were significantly overexpressed in CRC compared with NCs.
Journal ArticleDOI
The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
TL;DR: The plasma miR-205-5p level may reflect the change trend of the histological grade of OC patients and may be noninvasive diagnostic biomarkers of OC.
Journal ArticleDOI
Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.
Xia Shan,Huo Zhang,Lan Zhang,Xin Zhou,Tongshan Wang,Jinying Zhang,Yongqian Shu,Wei Zhu,Wei Wen,Ping Liu +9 more
TL;DR: A four‐miRNA peripheral plasma signature was established, which contributed to diagnosing male LSCC patients in China to a certain degree.
Journal ArticleDOI
Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma
TL;DR: A five-miRNA panel in peripheral serum samples as a non-invasive biomarker in detection of GCA was identified and significantly up-regulated in GCA tissues.
Journal ArticleDOI
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study
TL;DR: The results indicated that CIKs immunotherapy can be an effective adjuvant instrument of the routine therapy of malignancy.